INVZ · Innoviz Technologies Ltd.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-04 | Luski Ido |
Chief Operating Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 64,688 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 230,260 ordinary shares issuable upon vesting of RSUs; of which (a) 1,949 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,304 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 9,803 RSUs granted February 27, 2024, with 1,956 vesting quarterly through 2027 and 7,847 vesting quarterly through 2028; (d) 19,089 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,343 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 66,252 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 46,832 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 64,688 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. |
Ordinary Shares
|
64,688 |
| 2026-08-04 | Moscovici Avishay Ben |
Chief R&D Officer |
Award↑
Filing footnotes — Share Option (Direct)
Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. |
Share Option
|
71,072 |
| 2026-08-04 | Luski Ido |
Chief Operating Officer |
Award↑
Filing footnotes — Share Option (Direct)
Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. |
Share Option
|
69,296 |
| 2026-08-04 | Moscovici Avishay Ben |
Chief R&D Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 66,336 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 213,724 ordinary shares issuable upon vesting of RSUs; of which (a) 2,005 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,540 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 12,471 RSUs granted February 27, 2024, with 2,013 vesting quarterly through 2027 and 10,458 vesting quarterly through 2028; (d) 25,452 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,684 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 37,188 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 48,048 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 66,336 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. |
Ordinary Shares
|
66,336 |
| 2026-08-04 | Cegla Eldar Mordechay |
Chief Financial Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 73,184 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 234,628 ordinary shares issuable upon vesting of RSUs; of which (a) 2,607 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 11,104 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 13,109 RSUs granted February 27, 2024, with 2,616 vesting quarterly through 2027 and 10,493 vesting quarterly through 2028; (d) 25,524 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 15,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,016 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 73,184 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. |
Ordinary Shares
|
73,184 |
| 2026-08-04 | Cegla Eldar Mordechay |
Chief Financial Officer |
Award↑
Filing footnotes — Share Option (Direct)
Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. |
Share Option
|
78,416 |
| 2026-08-04 | Har Even Yoav |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 90,162 Restricted Share Units (RSUs) granted on August 4, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. |
Ordinary Shares
|
90,162 |
| 2026-08-04 | Hofstetter Elad Ben |
Chief Business Officer |
Award↑
Filing footnotes — Share Option (Direct)
Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. |
Share Option
|
57,968 |
| 2026-08-04 | Hofstetter Elad Ben |
Chief Business Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 54,112 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 176,964 ordinary shares issuable upon vesting of RSUs; of which (a) 1,782 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 7,592 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 10,454 RSUs granted February 27, 2024, with 1,788 vesting quarterly through 2027 and 8,666 vesting quarterly through 2028; (d) 21,087 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 11,341 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 30,804 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 54,112 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. |
Ordinary Shares
|
54,112 |
| 2026-07-07 | Keilaf Omer David |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Share Option (Direct)
Immediately exercisable. Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. |
Share Option
|
510,222 |
| 2026-07-07 | Keilaf Omer David |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Share Option (Direct)
Share options granted on August 1, 2023. The balance reported includes 54,945 vested options and 36,630 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. |
Share Option
|
25,641 |
| 2026-07-07 | Keilaf Omer David |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Share Option (Direct)
Immediately exercisable. Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. |
Share Option
|
342,408 |
| 2026-07-07 | Keilaf Omer David |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Ordinary Shares (Direct)
Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. The amount includes 916,552 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 7,798 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 62,978 RSUs granted February 27, 2024, with 10,674 vesting quarterly through 2027 and 52,304 vesting quarterly through 2028; (d) 54,531 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 75,251 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 562,500 RSUs granted May 26, 2025, vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. No consideration was paid in connection with the transfer. No exercise price is applicable. |
Ordinary Shares
|
679,400 |
| 2026-07-07 | Keilaf Omer David |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Share Option (Direct)
Share options granted on August 9, 2022. The balance reported includes 58,480 vested options and 5,848 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II. |
Share Option
|
29,240 |
| 2026-05-13 | Aharon Aharon |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 234,329 ordinary shares. |
Ordinary Shares
|
110,668 |
| 2026-05-13 | Von Witzleben Alexander Reymar Karl-Wilhelm |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 186,100 ordinary shares. |
Ordinary Shares
|
110,668 |
| 2026-05-13 | Falk Dan Michael |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 234,329 ordinary shares. |
Ordinary Shares
|
110,668 |
| 2026-05-13 | Jacoby Stefan |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 181,326 ordinary shares. |
Ordinary Shares
|
110,668 |
| 2026-05-13 | Sheridan James J. III |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 234,329 ordinary shares held directly by Mr. Sheridan, and 82,400 ordinary shares held by Perception Capital Partners, LLC. Mr. Sheridan is a director appointed by Perception Capital Partners, LLC and may be deemed to be the beneficial owner of the securities held by Perception Capital Partners, LLC. |
Ordinary Shares
|
110,668 |
| 2026-05-13 | Steimberg Amichai |
CEO - Orbotech Ltd. |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 265,602 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 723,734 ordinary shares. |
Ordinary Shares
|
265,602 |
| 2026-05-13 | Stav Orit |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 234,329 ordinary shares. |
Ordinary Shares
|
110,668 |
| 2026-05-13 | Maor Shenaar Ronit |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Includes 234,329 ordinary shares. |
Ordinary Shares
|
110,668 |
| 2026-04-30 | Keilaf Omer David |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Ordinary Shares (Direct)
Represents a transfer of 723,019 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, pursuant to a divorce settlement. The amount includes 1,135,780 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 15,596 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 74,008 RSUs granted February 27, 2024, with 14,232 vesting quarterly through 2027 and 59,776 vesting quarterly through 2028; (d) 60,590 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 82,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 750,000 RSUs granted May 26, 2025, one-fourth vesting on May 26, 2026, remainder vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. |
Ordinary Shares
|
723,019 |